The Role of Focal Adhesion Kinase in the TGF-β-Induced Myofibroblast Transdifferentiation of Human Tenon's Fibroblasts by Hong, Samin et al.
45
Original Article
The Role of Focal Adhesion Kinase in the TGF-β-Induced 
Myofibroblast Transdifferentiation of Human Tenon’s Fibroblasts
   
Samin Hong, Jong Bok Lee, Yoko Iizuka, Yoo Kyung Song, Gong Je Seong, Sueng-Han Han
Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea
pISSN: 1011-8942  eISSN: 2092-9382
Korean J Ophthalmol 2012;26(1):45-48
http://dx.doi.org/10.3341/kjo.2012.26.1.45
Myofibroblast transdifferentiation of activated fibro-
blasts is an essential step of the fibrotic process in most 
living tissues. Myofibroblasts have characteristics that are 
taken from both smooth muscle cells and fibroblasts; they 
express the contractile phenotype of α smooth muscle ac-
tin (αSMA) and synthesize extracellular matrix proteins 
including collagens [1-3]. In subconjunctival fibrosis, the 
myofibroblast transdifferentiation of Tenon’s fibroblasts is 
known to be mainly caused by transforming growth factor 
(TGF)-β [4-6]. Many ophthalmic researchers have sought 
to identify an anti-fibrotic mechanism by inhibiting TGF-β 
signaling [7-10].
Focal adhesion kinase (FAK), a cytosolic protein ty-
rosine kinase, provides scaffolding functions at sites of 
integrin adhesion and promotes cell migration [11,12]. 
The kinase modulates several basic processes in normal 
development and cancer metastasis. In addition, it also 
plays a crucial role in the transdifferentiation of fibroblasts 
to myofibroblasts induced by TGF-β [13-15]. However, 
because the precise action of the kinase is somewhat vari-
able based on the tissue [14,15], the role of FAK in myofi-
broblast transdifferentiation in human Tenon’s fibroblasts 
must be confirmed.
Using primary cultured human Tenon’s fibroblasts, the 
role of FAK in TGF-β-induced myofibroblast transdiffer-
entiation of human Tenon’s fibroblasts was investigated in 
the present study.
Materials and Methods
Cell culture and exposure to transforming growth factor-β1
After the Institutional Review Board approved our pro-
tocol, selected patients received comprehensive informa-
tion and provided written consent for inclusion. In compli-
ance with the tenets of the Declaration of Helsinki, small 
human Tenon’s capsule specimens were obtained during 
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Purpose: To investigate the role of focal adhesion kinase (FAK) in transforming growth factor (TGF)-β-induced 
myofibroblast transdifferentiation of human Tenon’s fibroblasts.
Methods: Primary cultured human Tenon’s fibroblasts were exposed to TGF-β1 for up to 48 hours. The mRNA 
levels of FAK, α smooth muscle actin (αSMA), and β-actin were determined by quantitative real time reverse 
transcription polymerase chain reaction. The protein levels of collagen type I, FAK, phospho-FAK, αSMA, and 
β-actin were determined by Western immunoblots. After the small interfering RNA targeting FAK (siRNAFAK) 
molecules were delivered into the cells, the expressions of αSMA proteins were determined by Western im-
munoblots.
Results: In human Tenon’s fibroblasts, TGF-β1 significantly increased the mRNA and protein expressions of 
αSMA. However, when the action of FAK was inhibited using siRNAFAK, the TGF-β1-induced expression of 
αSMA was attenuated.
Conclusions: Our data suggest that FAK may be associated with the TGF-β1-induced transdifferentiation of hu-
man Tenon’s fibroblasts to myofibroblasts, which is the essential step of subconjunctival fibrosis.
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strabismus surgery, and primary human Tenon’s fibroblasts 
were cultured from the explants. Cells were incubated in 
Dulbecco’s modified Eagle’s medium (DMEM; Life Tech-
nologies, Carlsbad, CA, USA) supplemented with 10% 
fetal bovine serum (Life Technologies), 100 units/mL peni-
cillin, and 100 μg/mL streptomycin (Life Technologies) at 
37°C in 5% CO2.
After 12 hours of incubation in serum-free media, the 
cells were treated with 5 ng/mL of recombinant human 
TGF-β1 (R&D Systems Inc., Minneapolis, MN, USA) for 
up to 48 hours. For the control group, the same volume of 
DMEM was added to the media instead of TGF-β1.
Small interfering RNAs targeting focal adhesion kinase
Small interfering RNA molecules targeting FAK mRNA 
(siRNAFAK) were purchased from Santa Cruz Biotechnol-
ogy Inc. (Santa Cruz, CA, USA) and were delivered into 
cells according to the manufacturer’s instructions. Briefly, 
the fibroblasts were incubated in media containing 50 nM 
of siRNAFAK and 2 μg/mL of Lipofectamine 2000 (Life 
Technologies) for 16 hours at 37°C in a CO2 incubator.
Real time reverse transcription polymerase chain reaction
Total RNA was extracted using an RNeasy Mini Kit 
(Qiagen, Venlo, Netherlands), and cDNAs were synthe-
sized using the SuperScript III First-Strand Synthesis 
System (Life Technologies). Real-time polymerase chain 
reaction (PCR) was performed with 50 ng cDNA per reac-
tion using 25 μL of iQ SYBR Green Supermix (Bio-Rad 
Laboratories, Hercules, CA, USA) containing 500 nM of 
specific primers (Table 1) in the iCycler iQ Real-Time PCR 
Detection System (Bio-Rad Laboratories). The SYBER 
green data were analyzed with a relative standard curve of 
β-actin.
Western immunoblots
Whole cellular proteins were extracted from the cells, 
and equal amounts of protein (10 μg) were resolved by so-
dium dodecyl sulfate polyacrylamide gel electrophoresis. 
The proteins were transferred to polyvinylidene fluoride 
membranes and probed overnight with primary antibod-
ies against human collagen type I, FAK, phospho-FAK 
(pFAK), αSMA, and β-actin (Santa Cruz Biotechnology). 
Immunoreactive bands were detected with horseradish 
peroxidase-conjugated secondary antibodies (Santa Cruz 
Biotechnology) and visualized with an enhanced chemilu-
minescent system.
Statistical analysis
Quantitative reverse transcription (RT)-PCR data is ex-
pressed as mean ± SEM and compared with the Kruskal-
Wallis one-way analysis of variance using the MedCalc 
ver. 11.4.2 (MedCalc Software bvba, Mariakerke, Bel-
gium). Image analysis of the immunobands was performed 
using the ImageJ ver. 1.43u (National Institutes of Health, 
Bethesda, MD, USA). A p-value less than 0.05 was consid-
Table 1. Primer sequences for reverse transcription polymerase chain reaction
Gene name Type   Sequence
FAK
Forward 5’-GAA GCA TTG GGT CGG GAA CTA-3’
Reverse 5’-CTC AAT GCA GTT TGG AGG TGC-3’
αSMA
Forward 5’-GTG TTA TGT AGC TCT GGA CTT TGA AAA-3’
Reverse 5’-GGC AGC GGA AAC GTT CAT T-3’
β-actin
Forward 5’-GCG GGA AAT CGT GCG TGA CAT T-3’
Reverse 5’-GAT GGA GTT GAA GGT AGT TTC GTG-3’
FAK = focal adhesion kinase; αSMA = α smooth muscle actin.
Fig. 1. Quantitative reverse transcription polymerase chain 
reaction for focal adhesion kinase (FAK) and α smooth muscle 
actin (αSMA) after exposure to 5 ng/mL of transforming 
growth factor-β1 for up to 16 hours. The level of target mRNA 
was calculated using a relative standard curve of β-actin and 
expressed as the mean ± SEM. 
*p < 0.05.47
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ered statistically significant.
Results
The quantitative data of RT-PCR for FAK and αSMA 
are presented in Fig. 1. In the human Tenon’s fibroblasts, 
the 16-hour treatment with TGF-β1 significantly increased 
the mRNA levels of αSMA (5.11 ± 1.37 times to control, p 
= 0.023) but not of FAK (1.16 ± 0.06 times to control, p = 
0.204).
On the Western immunoblots, the TGF-β1 treatment 
increased the protein expression of FAK as well as that 
of collagen type I. Expression of pFAK, an active form of 
FAK, was also increased. These changes were observed 
after 12 hours. Representative immunobands for collagen 
type I, FAK, pFAK, and β-actin are shown in Fig. 2.
Regarding αSMA, though serum starvation itself slightly 
induced the expression of αSMA, the exposure to TGF-β1 
for 48 hours stimulated αSMA expression in human Tenon’s 
fibroblasts. When the siRNAFAK molecules were introduced 
into the cells, the TGF-β1-induced αSMA expression was 
attenuated. Representative immunobands for αSMA in the 
control group, TGF-β1 only treatment group, and siRNAFAK/
TGF-β1 treatment group are shown in Fig. 3.
Discussion 
FAK, also known as protein tyrosine kinase 2, par-
ticipates in the focal adhesion between the cytoskeleton 
and extracellular matrix and elicits intracellular signal 
transductions associated with cell migration and survival 
[11,12,16-18]. It is activated by autophosphorylation via 
Smad- and p38 MAPK-dependent mechanisms [19-22] 
and plays a key role in cancer metastasis as well as normal 
development [11,12]. Even though FAK is also linked to 
the myofibroblast transdifferentiation of fibroblasts in re-
sponse to TGF-β1 [13-15], the precise role of the kinase has 
not been well studied in the fibrotic process in the subcon-
junctival space. Excessive subconjunctival fibrosis causes 
ocular morbidity in not only patients with ocularcutaneous 
disorders, but also patients who have undergone strabis-
mus surgery and/or glaucoma-filtering surgery. A better 
understanding and modulation of FAK signaling in this 
process may result in a novel therapeutic strategy for those 
patients.
Using primary cultured human Tenon’s fibroblasts, we 
investigated the role of FAK in TGF-β-induced myofibro-
blast transdifferentiation in the present study and found 
that silencing of FAK action using siRNAFAK duplex sig-
nificantly attenuated the αSMA expression induced by 
TGF-β1 in human Tenon’s fibroblasts. Our data implies that 
FAK may participate in the myofibroblast transdifferentia-
tion of those cells.
Myofibroblasts contain characteristics found in smooth 
muscle cells and fibroblasts in that they possess a con-
tractile phenotype of αSMA and synthesize extracellular 
matrix proteins [1-3]. Since they play a crucial role in most 
fibrotic responses, myofibroblast transdifferentiation from 
activated fibroblasts is an essential step in the fibrotic pro-
cess. In the subconjunctival space, TGF-β typically initi-
ates this myofibroblast transdifferentiation of fibroblasts 
[4-6].
On quantitative RT-PCR, the mRNA expression of 
αSMA was dramatically increased by TGF-β1, but FAK 
was not significantly altered. However, on Western im-
munoblots, the protein levels of both FAK and pFAK were 
minimally stimulated by TGF-β1 treatment. The increase 
in FAK seems to result from an increase in translation 
rather than transcription.
Currently, many researchers have tried to develop anti-
TGF-β neutralizing antibodies to modulate postoperative 
scarring in patients undergoing ocular surface surgery [23-
25]. FAK, as a participant in TGF-β-associated intracel-
lular signaling of myofibroblast transdifferentiation from 
fibroblasts, might also be valuable as a novel therapeutic 
Fig. 2. Representative Western immunoblots and densitomet-
ric data for collagen type I (190 kDa), focal adhesion kinase 
(FAK, 125 kDa), phospho-FAK (pFAK, 125 kDa), and β-actin 
(43 kDa) in human Tenon’s fibroblasts stimulated by 5 ng/mL 
of transforming growth factor-β1 for up to 48 hours.
Collagen type Ⅰ
FAK
pFAK
β-actin
 0  1  3  6  12  24  48  (hr)
  1.00  0.76  0.84  1.08  1.67  1.94  2.02
  1.00  0.99  0.82  1.47  2.05  2.25  1.84
  1.00  0.89  2.87  3.40  5.56  5.31  6.17
  1.00  1.03  1.05  1.02  1.04  1.07  1.13
Fig. 3. Representative Western immunoblots and densitometric 
data for α smooth muscle actin (43 kDa) in human Tenon’s fi-
broblasts stimulated by 5 ng/mL of transforming growth factor 
(TGF)-β1 for up to 48 hours with or without the treatment of 
siRNA targeting FAK (siRNAFAK) molecules.
No treatment
siRNAFAK + TGF-β1 (5 ng/mL)
TGF-β1 (5 ng/mL)
 0  1  3  6  12  24  48  (hr)
  1.00  0.83  0.84  1.29  0.87  3.61  7.11
  1.00  0.95  1.19  1.18  3.30  6.45  78.27
  1.00  0.91  1.02  1.41  1.44  3.04  37.6348
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strategy for anti-fibrosis.
Conflict of Interest 
No potential conflict of interest relevant to this article 
was reported.
Acknowledgements
This work was supported by a Faculty Research Grant 
from the Yonsei University College of Medicine, Seoul, 
Republic of Korea (6-2008-0274).
References
1.  Eyden B. The myofibroblast: an assessment of controversial 
issues and a definition useful in diagnosis and research. Ul-
trastruct Pathol 2001;25:39-50.
2.  Eyden B. Electron microscopy in the study of myofibro-
blastic lesions. Semin Diagn Pathol 2003;20:13-24.
3.  Desmouliere A, Guyot C, Gabbiani G. The stroma reaction 
myofibroblast: a key player in the control of tumor cell be-
havior. Int J Dev Biol 2004;48:509-17.
4.  Meyer-Ter-Vehn T, Grehn F, Schlunck G. Localization of 
TGF-beta type II receptor and ED-A fibronectin in normal 
conjunctiva and failed filtering blebs. Mol Vis 2008;14:136-
41.
5.  Saika S, Yamanaka O, Okada Y, et al. TGF beta in fibropro-
liferative diseases in the eye. Front Biosci (Schol Ed) 2009;
1:376-90.
6.  Seong GJ, Hong S, Jung SA, et al. TGF-beta-induced in-
terleukin-6 participates in transdifferentiation of human 
Tenon’s fibroblasts to myofibroblasts. Mol Vis 2009;15:2123-
8.
7.  Nakamura H, Siddiqui SS, Shen X, et al. RNA interference 
targeting transforming growth factor-beta type II recep-
tor suppresses ocular inflammation and fibrosis. Mol Vis 
2004;10:703-11.
8.  Meyer-Ter-Vehn T, Gebhardt S, Sebald W, et al. p38 inhibi-
tors prevent TGF-beta-induced myofibroblast transdiffer-
entiation in human tenon fibroblasts. Invest Ophthalmol Vis 
Sci 2006;47:1500-9.
9.  Yamanaka O, Saika S, Ikeda K, et al. Interleukin-7 modu-
lates extracellular matrix production and TGF-beta signal-
ing in cultured human subconjunctival fibroblasts. Curr 
Eye Res 2006;31:491-9.
10.  Meyer-Ter-Vehn T, Katzenberger B, Han H, et al. Lovas-
tatin inhibits TGF-beta-induced myofibroblast transdiffer-
entiation in human tenon fibroblasts. Invest Ophthalmol Vis 
Sci 2008;49:3955-60.
11.  Chatzizacharias NA, Kouraklis GP, Theocharis SE. The 
role of focal adhesion kinase in early development. Histol 
Histopathol 2010;25:1039-55.
12.  Schwock J, Dhani N, Hedley DW. Targeting focal adhesion 
kinase signaling in tumor growth and metastasis. Expert 
Opin Ther Targets 2010;14:77-94.
13.  Thannickal VJ, Lee DY, White ES, et al. Myofibroblast 
differentiation by transforming growth factor-beta1 is de-
pendent on cell adhesion and integrin signaling via focal 
adhesion kinase. J Biol Chem 2003;278:12384-9.
14.  Mimura Y, Ihn H, Jinnin M, et al. Constitutive phosphory-
lation of focal adhesion kinase is involved in the myofi-
broblast differentiation of scleroderma fibroblasts. J Invest 
Dermatol 2005;124:886-92.
15.  Brenmoehl J, Miller SN, Hofmann C, et al. Transforming 
growth factor-beta 1 induces intestinal myofibroblast dif-
ferentiation and modulates their migration. World J Gas-
troenterol 2009;15:1431-42.
16.  McLean GW, Carragher NO, Avizienyte E, et al. The role 
of focal-adhesion kinase in cancer: a new therapeutic op-
portunity. Nat Rev Cancer 2005;5:505-15.
17.  Cox BD, Natarajan M, Stettner MR, Gladson CL. New 
concepts regarding focal adhesion kinase promotion of cell 
migration and proliferation. J Cell Biochem 2006;99:35-52.
18.  Liu S, Xu SW, Kennedy L, et al. FAK is required for TGF-
beta-induced JNK phosphorylation in fibroblasts: implica-
tions for acquisition of a matrix-remodeling phenotype. 
Mol Biol Cell 2007;18:2169-78.
19.  Horowitz JC, Rogers DS, Sharma V, et al. Combinato-
rial activation of FAK and AKT by transforming growth 
factor-beta1 confers an anoikis-resistant phenotype to myo-
fibroblasts. Cell Signal 2007;19:761-71.
20.  Parsons CJ, Takashima M, Rippe RA. Molecular mecha-
nisms of hepatic fibrogenesis. J Gastroenterol Hepatol 
2007;22 Suppl 1:S79-84.
21.  Walsh MF, Ampasala DR, Hatfield J, et al. Transforming 
growth factor-beta stimulates intestinal epithelial focal 
adhesion kinase synthesis via Smad- and p38-dependent 
mechanisms. Am J Pathol 2008;173:385-99.
22.  Walsh MF, Ampasala DR, Rishi AK, Basson MD. TGF-
beta1 modulates focal adhesion kinase expression in rat 
intestinal epithelial IEC-6 cells via stimulatory and in-
hibitory Smad binding elements. Biochim Biophys Acta 
2009;1789:88-98.
23.  Cordeiro MF. Technology evaluation: lerdelimumab, Cam-
bridge Antibody Technology. Curr Opin Mol Ther 2003;
5:199-203.
24.  Mead AL, Wong TT, Cordeiro MF, et al. Evaluation of anti-
TGF-beta2 antibody as a new postoperative anti-scarring 
agent in glaucoma surgery. Invest Ophthalmol Vis Sci 
2003;44:3394-401.
25.  CAT-152 0102 Trabeculectomy Study Group, Khaw P, 
Grehn F, et al. A phase III study of subconjunctival human 
anti-transforming growth factor beta(2) monoclonal anti-
body (CAT-152) to prevent scarring after first-time trabecu-
lectomy. Ophthalmology 2007;114:1822-30.